Sub-Q Bionics, a medical device company focused on lymphedema solutions, has secured $1.5 million in pre-seed funding. The round saw participation from notable investors including Mayo Clinic and Yeda, the technology transfer arm of the Weizmann Institute of Science. The Israel Innovation Authority also contributed matching funds to support the company's development.